Affordable and Effective Pharma Treatment
RMDM Pharma is the pharmaceutical wing of the RMDM Group.
It provides the third link in our comprehensive three-pronged approach to preventing, detecting and treating cancer.
Currently in the early stages, our team is conducting clinical trials for the release of a prodrug that renders current cancer treatments more effective.
Developed and patented by Dr. Johannes Coy and his team in Germany, this pro-drug – Oxybenfothiamine – hinders the activity of TKTL1 and decelerates the metabolisation of cancerous cells.
Combined with the early detection made possible by the Pantum Detect test, this affordable and effective treatment represents a paradigm shift in the treatment of cancer, allowing us to effectively fight even the most malignant and chemotherapy-resistant tumours.
Cutting-Edge Research Delivered to Local Markets
Working with our partners in Germany, we are on the verge of phase one trials and hope to have the pro-drug available by 2022.
RMDM Pharma funnels this innovative research into local delivery throughout the UK and the Middle East and North Africa (MENA).
Please contact us should you like to know more about this pro-drug or if you would like to be informed of RMDM Pharma’s news and developments.
Getting To Know Dr Coy's Sugars
Tagatose
Galactose
Isomaltulose
Trehalose
Ribose
Erythritol
Tagatose
Tagatose, is a sweet, simple sugar (monosaccharide) with a very low glycaemic index and low-calorie content. Tagatose stabilises blood glucose levels. A small amount is absorbed in the small intestine, and the remainder is excreted or fermented.
Galactose
Galactose, is a simple sugar (monosaccharide) like glucose, but with a lower glycaemic index, which means it doesn’t lead to a fast blood glucose increase and blood sugar levels remain stable.
Isomaltulose
Isomaltulose is a natural double sugar (disaccharide) which consists of the same components as conventional household sugar – glucose and fructose – but has a lower glycaemic index.
Trehalose
Trehalose, is a natural double sugar (disaccharide) composed of two glucose molecules. Many plants, fungi, bacteria, and some insects use trehalose to protect proteins in their cells against protein damage.
Ribose
Ribose is a simple sugar which forms the building blocks of DNA. It’s an essential component of adenosine triphosphate (ATP), which is the primary molecule that stores and transfers energy in our cells. It’s the least sweet sugar.
Erythritol
Erythritol is a calorie-free and tooth-friendly sugar alcohol (polyol), that has no negative effects on blood glucose levels. It’s found in honey, grapes, melons and other fruits.
Getting To Know Dr Coy's Sugars
Tagatose
Tagatose, is a sweet, simple sugar (monosaccharide) with a very low glycaemic index and low-calorie content. Tagatose stabilises blood glucose levels. A small amount is absorbed in the small intestine, and the remainder is excreted or fermented.
Galactose
Galactose, is a simple sugar (monosaccharide) like glucose, but with a lower glycaemic index, which means it doesn’t lead to a fast blood glucose increase and blood sugar levels remain stable.
Isomaltulose
Isomaltulose is a natural double sugar (disaccharide) which consists of the same components as conventional household sugar – glucose and fructose – but has a lower glycaemic index.
Trehalose
Trehalose, is a natural double sugar (disaccharide) composed of two glucose molecules. Many plants, fungi, bacteria, and some insects use trehalose to protect proteins in their cells against protein damage.
Ribose
Ribose is a simple sugar which forms the building blocks of DNA. It’s an essential component of adenosine triphosphate (ATP), which is the primary molecule that stores and transfers energy in our cells. It’s the least sweet sugar.
Erythritol
Erythritol is a calorie-free and tooth-friendly sugar alcohol (polyol), that has no negative effects on blood glucose levels. It’s found in honey, grapes, melons and other fruits.
Other Resources You Might Find Useful
Scotland’s £10 Million Investment to Improve Cancer Care
This week we are excited to share the news of an incredible commitment to early cancer detection by the Scottish Government. A £10 million fund has been granted to improve cancer waiting times. The fund will enable the NHS in Scotland to invest in staff skills, new diagnostic tests, and…
COVID-19 Hits Breast Cancer Screenings
Breast cancer is the most common cancer in the UK, with around 12,000 women diagnosed with the condition every year. Unfortunately, this week an analysis of NHS England figures by Cancer Research UK has found that around 10,600 fewer women started treatment for breast cancer in 2020, compared to the…
Cervical Cancer and the Need For Less Invasive Screening
Did you know 14th – 20th June 2021 is cervical screening awareness week? Cervical screening, also known as a smear test, is used to check the health of the cervix. It’s also the primary method used of detecting abnormal cells early, before they develop into cancer. The current government guidelines recommend that…
Focus on Cancer Research: For Diagnosis and Treatment
In some parts of the world, May is National Cancer Research Month – a month dedicated to highlighting the importance of lifesaving research into the devastating group of diseases collectively called cancer. Cancer affects millions of people across the globe. Statistics show that in 2018, there were more than 17 million new…
Growing Cancer Diagnoses in the Middle East
This week we were shocked by news of a new study in the Middle East. This study has found that young people across the UAE and Saudi Arabia are four times more likely to be diagnosed with cancer than their counterparts in the U.K and United States. We know that cancer doesn’t…